Skip to content
Tenfell
Awarded contract
Published 30 Mar 2026

NP49425 Generic and Biosimilar Transition Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · Scotland

Key facts

Awarded
18 Dec 2025
Buyer type
Health

Awarded to 31 suppliers

SupplierValue
FRESENIUS KABI LIMITED—
Takeda UK Limited—
Celix Pharma Ltd.—
Janssen-Cilag Ltd—
MSN Labs—
Pfizer Ltd—
STADA UK - Thornton & Ross—
Teva UK Ltd—
Viatris UK Healthcare Ltd—
Accord Healthcare Ltd—
Amgen Ltd—
Mercury Pharma Group—
Sandoz Ltd—
Celltrion Healthcare United Kingdom Limited—
Gedeon Richter UK Ltd—
Roche Products Ltd—
Zentiva Pharma UK Ltd—
Amarox Limited—
Brown & Burk UK Ltd—
Glenmark Pharmaceuticals Europe Ltd—
Dr Falk Pharma UK Ltd—
Ferring Pharmaceuticals Limited—
Lupin Healthcare UK Ltd—
Vifor Pharma UK Limited—
Zydus Pharmaceuticals UK Ltd—
AOP Orphan Ltd—
Chiesi Limited—
Perennial Pharma Ltd—
Theramex HQ UK—
Samsung Bioepis Ltd—
SERB SA—

Description

Supply of generic cand biosimilar transition medicines to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Categories (CPV)

Similar open tenders

About The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Public Contracts Scotland (Open Government Licence v3.0). Always read the original notice before responding.